Surgery Partners, Inc. announced changes to its merger deal, raising cash per share and adjusting fees.

Nov 9, 2026, 9:27 AM ETDealRead the original at SEC EDGAR

Good for SGRY

Surgery Partners raised the cash offer per share and added possible monthly payments if closing is delayed. A larger fee for ending the deal may limit alternatives, but the higher offer and stronger buyer obligations favor shareholders.

SGRY · Surgery Partners, Inc.

AI read · Good for SGRY

The AI's read

The buyer must now take all actions needed to clear competition barriers, which could help the deal close. Surgery Partners also faces a larger fee if it ends the deal, plus up to $8.25 million in expenses for certain exits. Those terms limit alternatives, but the higher cash offer and stronger buyer obligation matter more. The deal still needs approval and must close.

Get alerts for SGRY

Follow Surgery Partners, Inc. (SGRY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SGRY

Free on the App Store and Google Play, or on the web.